HTHongying Tang

Hongying Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hongying Tang has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Yanping Li

    Reproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, People’s Republic of China

    4 shared publications
  • Bin Xu

    Department of Reproductive Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China

    2 shared publications
  • Fen Tian

    Department of Reproductive Medicine, Xiangya Hospital, Central South University, Changsha, People’s Republic of China

    2 shared publications
  • Ge Yang

    Division of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong, China

    2 shared publications
  • Hui Li

    Department of Reproductive Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China

    2 shared publications
  • Huiyu Qiu

    Department of Reproductive Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China

    2 shared publications

Latest Publications

  • Open Access

    Integrated Prediction System for Individualized Ovarian Stimulation and Ovarian Hyperstimulation Syndrome Prevention: Algorithm Development and Validation

    by Jingjing Chen, Jianjuan Zhao, Huiyu Qiu, Yanhui Liu, Yunqi Zhang, Qicheng Sun, Yan Yi, Hongying Tang, Jing Zhao, Bin Xu, et al.

    Background: Accurately predicting ovarian response and determining the optimal starting dose of follicle-stimulating hormone (FSH) remain critical yet challenging for effective ovarian stimulation. Currently, there is a lack of a comprehensive model capable of simultaneously forecasting the number of oocytes retrieved (NOR) and assessing the risk of early-onset moderate-to-severe ovarian hyperstimulation syndrome (OHSS). Objective: This study aimed to establish an integrated mode capable of forecasting the NOR and assessing the risk of early-onset moderate-to-severe OHSS across varying starting doses of FSH. Methods: This prognostic study included patients undergoing their first ovarian stimulation cycles at 2 independent in vitro fertilization clinics. Automated classifiers were used for variable selection. Machine learning models (11 for NOR and 11 for OHSS) were developed and validated using internal (n=6401) and external (n=3805) datasets. Shapley additive explanation was applied for variable interpretation. The best-performing models were incorporated into a web-based prediction tool. Results: For NOR prediction, 17 variables were selected, with the gradient boosting regressor achieving the highest performance (internal dataset: R2=0.7978; external dataset: R2=0.7924). For OHSS prediction, 19 variables were identified, and the LightGBM model demonstrated superior performance (internal dataset: area under the receiver operating characteristic curve=0.7588; external dataset: area under the receiver operating characteristic curve=0.7287). Shapley additive explanation analysis highlighted the FSH starting dose to BMI ratio and baseline antral follicle count as key predictors for NOR and OHSS, respectively. Dose-response curves were generated to visualize predicted outcomes with varying FSH starting doses. The models were implemented in a user-friendly, research-oriented online prototype, individualized ovarian stimulation guide (InOvaSGuide). Conclusions: This study introduces an integrated framework for predicting NOR and early-onset moderate-to-severe OHSS risk across different FSH doses. Future prospective evaluation is needed before clinical implementation.


  • Open Access

    Integrated Prediction System for Individualized Ovarian Stimulation and Ovarian Hyperstimulation Syndrome Prevention: Algorithm Development and Validation (Preprint)

    by Jingjing Chen, Jianjuan Zhao, Huiyu Qiu, Yanhui Liu, Yunqi Zhang, Qicheng Sun, Yan Yi, Hongying Tang, Jing Zhao, Bin Xu, et al.

    BACKGROUND Accurately predicting ovarian response and determining the optimal starting dose of follicle-stimulating hormone (FSH) remain critical yet challenging for effective ovarian stimulation. Currently, there is a lack of a comprehensive model capable of simultaneously forecasting the number of oocytes retrieved (NOR) and assessing the risk of early-onset moderate-to-severe ovarian hyperstimulation syndrome (OHSS). OBJECTIVE This study aimed to establish an integrated mode capable of forecasting the NOR and assessing the risk of early-onset moderate-to-severe OHSS across varying starting doses of FSH. METHODS This prognostic study included patients undergoing their first ovarian stimulation cycles at 2 independent in vitro fertilization clinics. Automated classifiers were used for variable selection. Machine learning models (11 for NOR and 11 for OHSS) were developed and validated using internal (n=6401) and external (n=3805) datasets. Shapley additive explanation was applied for variable interpretation. The best-performing models were incorporated into a web-based prediction tool. RESULTS For NOR prediction, 17 variables were selected, with the gradient boosting regressor achieving the highest performance (internal dataset: R2=0.7978; external dataset: R2=0.7924). For OHSS prediction, 19 variables were identified, and the LightGBM model demonstrated superior performance (internal dataset: area under the receiver operating characteristic curve=0.7588; external dataset: area under the receiver operating characteristic curve=0.7287). Shapley additive explanation analysis highlighted the FSH starting dose to BMI ratio and baseline antral follicle count as key predictors for NOR and OHSS, respectively. Dose-response curves were generated to visualize predicted outcomes with varying FSH starting doses. The models were implemented in a user-friendly, research-oriented online prototype, individualized ovarian stimulation guide (InOvaSGuide). CONCLUSIONS This study introduces an integrated framework for predicting NOR and early-onset moderate-to-severe OHSS risk across different FSH doses. Future prospective evaluation is needed before clinical implementation.

  • Open Access

    An endometrium of type C along with an endometrial thickness of < 8 mm are risk factors for ectopic pregnancy after stimulated cycles with fresh embryo transfer

    by Ying Zhao, Aizhuang Xu, Dong’e Liu, Nenghui Liu, Yumei Li, Zhongyuan Yao, Fen Tian, Hongying Tang, Yanping Li

    Background: The study investigated whether specific ultrasonographically observed endometrial features (including endometrium type and thickness) were linked to ectopic pregnancy after stimulated cycles with fresh embryo transfer. Method: Of 6246 pregnancy cycles after fresh embryo transfer, 6076 resulted in intrauterine pregnancy and 170 in ectopic pregnancy. The primary outcome of the study was ectopic pregnancy, with the main variables being endometrium type and endometrial thickness. Univariate and subsequent multiple-stepwise logistic regression analyses were used to identify the risk factors of ectopic pregnancy. Results: 1. Compared with patients with an endometrial thickness ≥ 8 mm, the adjusted odds ratio for those with an endometrial thickness < 8 mm was 3.368 (P < 0.001). The adjusted odds ratio for women with a type-C endometrium was 1.897 (P = 0.019) compared with non-type C. 2. A larger dose of gonadotropin used during controlled ovarian hyperstimulation was a protective factor against ectopic pregnancy (P = 0.008). 3. The GnRH antagonist protocol (P = 0.007) was a risk factor for ectopic pregnancy, compared with the use of GnRH agonists. Conclusion: (1) An endometrial thickness < 8 mm coupled with a type C endometrium significantly increased the risk of ectopic pregnancy after fresh embryo transfer. (2) A thin endometrial thickness and a type C endometrium could be further related to an abnormal endometrial receptivity/peristaltic wave. (3) Patients at a high risk of ectopic pregnancy should therefore be given special attention, with early diagnosis during the peri-transplantation period may assist in the prevention of ectopic pregnancy.


  • Associations between dyslipidaemia and pregnancy outcomes in the first complete cycle of IVF/ICSI: a real-world analysis

    by Tianli Yang, Jing Zhao, Qiong Zhang, Donge Liu, Nenghui Liu, Yumei Li, Zhongyuan Yao, Yeqing Zhang, Fen Tian, Tingting Liao, et al.